Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistSupergoop! was cited for marketing "Supergoop! PLAY SPF 50 BODY MOUSSE" as an unapproved over-the-counter drug without an FDA-approved new drug application, despite labeling and promotional claims (including on its website and Instagram) that explicitly identified the product as a broad-spectrum sunscreen intended to prevent sunburn. The company violated FDA regulations by making drug claims—such as "helps prevent sunburn" and describing it as a "sunscreen mousse with SPF 50 protection"—without obtaining the required FDA approval under section 505 of the FD&C Act. The violations were identified during an FDA review of the product labeling, website, and social media pages conducted on May 2, 2025.